| scholarly article | Q13442814 |
| P50 | author | Barbara Picconi | Q42663948 |
| Veronica Ghiglieri | Q42883463 | ||
| Carmelo Sgobio | Q60619673 | ||
| P2093 | author name string | Paolo Calabresi | |
| Valentina Pendolino | |||
| Vincenza Bagetta | |||
| Francesca R Fusco | |||
| Carmen Giampà | |||
| Silvia Marinucci | |||
| P2860 | cites work | Distinct levels of dopamine denervation differentially alter striatal synaptic plasticity and NMDA receptor subunit composition. | Q42852538 |
| Dopamine modulation of excitatory currents in the striatum is dictated by the expression of D1 or D2 receptors and modified by endocannabinoids. | Q43187066 | ||
| Postsynaptic endocannabinoid release is critical to long-term depression in the striatum | Q43971441 | ||
| Loss of bidirectional striatal synaptic plasticity in L-DOPA-induced dyskinesia | Q44383212 | ||
| Differential electrophysiological properties of dopamine D1 and D2 receptor-containing striatal medium-sized spiny neurons | Q44463501 | ||
| Different synaptic and subsynaptic localization of adenosine A2A receptors in the hippocampus and striatum of the rat. | Q46460712 | ||
| Opposing patterns of signaling activation in dopamine D1 and D2 receptor-expressing striatal neurons in response to cocaine and haloperidol | Q46570512 | ||
| Differential tonic GABA conductances in striatal medium spiny neurons | Q46782245 | ||
| Selective elimination of glutamatergic synapses on striatopallidal neurons in Parkinson disease models. | Q46896175 | ||
| l-DOPA dosage is critically involved in dyskinesia via loss of synaptic depotentiation | Q46904268 | ||
| Non-motor behavioural impairments in parkin-deficient mice. | Q46990501 | ||
| Bregma, lambda and the interaural midpoint in stereotaxic surgery with rats of different sex, strain and weight | Q47226476 | ||
| Thigmotaxis as an index of anxiety in mice. Influence of dopaminergic transmissions | Q48153919 | ||
| Glutamate-triggered events inducing corticostriatal long-term depression. | Q48162644 | ||
| Effects of medial and lateral caudate-putamen lesions on place- and cue-guided behaviors in the water maze: relation to thigmotaxis | Q48231377 | ||
| Coactivation of D1 and D2 dopamine receptors is required for long-term synaptic depression in the striatum | Q48446136 | ||
| Neuroleptic-like disruption of the conditioned avoidance response requires destruction of both the mesolimbic and nigrostriatal dopamine systems | Q48656916 | ||
| The Distinct Role of Medium Spiny Neurons and Cholinergic Interneurons in the D2/A2A Receptor Interaction in the Striatum: Implications for Parkinson's Disease | Q60715991 | ||
| Short- and long-term synaptic depression in rat neostriatum | Q72665515 | ||
| Striatal medium-sized spiny neurons: identification by nuclear staining and study of neuronal subpopulations in BAC transgenic mice | Q21143854 | ||
| Nigrostriatal dopaminergic deficits and hypokinesia caused by inactivation of the familial Parkinsonism-linked gene DJ-1 | Q28506681 | ||
| The molecular biology of memory storage: a dialogue between genes and synapses | Q29547845 | ||
| D1 and D2 dopamine receptor-regulated gene expression of striatonigral and striatopallidal neurons | Q29615480 | ||
| A gene expression atlas of the central nervous system based on bacterial artificial chromosomes | Q29617753 | ||
| Requirement of dopamine signaling in the amygdala and striatum for learning and maintenance of a conditioned avoidance response. | Q30470056 | ||
| Dichotomous dopaminergic control of striatal synaptic plasticity | Q30493521 | ||
| Differential perikaryal localization in rats of D1 and D2 dopamine receptors on striatal projection neuron types identified by retrograde labeling | Q33254262 | ||
| Distribution, biochemistry and function of striatal adenosine A2A receptors | Q33740841 | ||
| Dopaminergic control of corticostriatal long-term synaptic depression in medium spiny neurons is mediated by cholinergic interneurons. | Q34521936 | ||
| Multiple parallel memory systems in the brain of the rat. | Q34534214 | ||
| Dopamine-dependent synaptic plasticity in striatum during in vivo development | Q34658296 | ||
| Dopamine D2 receptor overexpression alters behavior and physiology in Drd2-EGFP mice | Q34780457 | ||
| The lesion of the rat substantia nigra pars compacta dopaminergic neurons as a model for Parkinson's disease memory disabilities. | Q35018690 | ||
| Anatomy of adenosine A2A receptors in brain: morphological substrates for integration of striatal function | Q35603262 | ||
| The neostriatal mosaic: multiple levels of compartmental organization in the basal ganglia | Q36064948 | ||
| The basal ganglia: learning new tricks and loving it. | Q36306845 | ||
| A convergent model for cognitive dysfunctions in Parkinson's disease: the critical dopamine-acetylcholine synaptic balance. | Q36628908 | ||
| Dopamine-mediated regulation of corticostriatal synaptic plasticity. | Q36762821 | ||
| Neuronal networks and synaptic plasticity in Parkinson's disease: beyond motor deficits. | Q37082026 | ||
| Short-term and long-term plasticity at corticostriatal synapses: implications for learning and memory. | Q37307179 | ||
| Neurotransmitter roles in synaptic modulation, plasticity and learning in the dorsal striatum | Q37680104 | ||
| Synaptic dysfunction in Parkinson's disease. | Q37713858 | ||
| Levodopa-induced dyskinesias in patients with Parkinson's disease: filling the bench-to-bedside gap. | Q37794467 | ||
| Inhibition of phosphodiesterases rescues striatal long-term depression and reduces levodopa-induced dyskinesia. | Q39801798 | ||
| The effects of dorsal bundle injections of 6-hydroxydopamine on avoidance responding in rats | Q40058656 | ||
| Histone H3 phosphorylation is under the opposite tonic control of dopamine D2 and adenosine A2A receptors in striatopallidal neurons. | Q41814232 | ||
| Long-term synaptic depression in the striatum: physiological and pharmacological characterization | Q42453585 | ||
| A model of L-DOPA-induced dyskinesia in 6-hydroxydopamine lesioned mice: relation to motor and cellular parameters of nigrostriatal function | Q42463405 | ||
| Immunohistochemical demonstration of differential substance P-, met-enkephalin-, and glutamic-acid-decarboxylase-containing cell body and axon distributions in the corpus striatum of the cat. | Q42495375 | ||
| Endocannabinoid-mediated rescue of striatal LTD and motor deficits in Parkinson's disease models | Q42508054 | ||
| P433 | issue | 35 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Parkinson's disease | Q11085 |
| dopamine | Q170304 | ||
| striatum | Q1319792 | ||
| P304 | page(s) | 12513-12522 | |
| P577 | publication date | 2011-08-01 | |
| P1433 | published in | Journal of Neuroscience | Q1709864 |
| P1476 | title | Dopamine-dependent long-term depression is expressed in striatal spiny neurons of both direct and indirect pathways: implications for Parkinson's disease | |
| P478 | volume | 31 |
| Q36168175 | A comparison of striatal-dependent behaviors in wild-type and hemizygous Drd1a and Drd2 BAC transgenic mice |
| Q42551069 | A feud that wasn't: acetylcholine evokes dopamine release in the striatum |
| Q36681301 | A novel dopamine transporter transgenic mouse line for identification and purification of midbrain dopaminergic neurons reveals midbrain heterogeneity |
| Q39502291 | A role for dopamine-mediated learning in the pathophysiology and treatment of Parkinson's disease. |
| Q28728678 | A2A adenosine receptor antagonism enhances synaptic and motor effects of cocaine via CB1 cannabinoid receptor activation |
| Q36938284 | Acetylcholine encodes long-lasting presynaptic plasticity at glutamatergic synapses in the dorsal striatum after repeated amphetamine exposure. |
| Q27330422 | C. elegans dopaminergic D2-like receptors delimit recurrent cholinergic-mediated motor programs during a goal-oriented behavior |
| Q38686736 | Cell Therapy in Parkinson's Disease: Host Brain Repair Machinery Gets a Boost From Stem Cell Grafts. |
| Q38809530 | Chronic Nicotine Alters Corticostriatal Plasticity in the Striatopallidal Pathway Mediated By NR2B-Containing Silent Synapses |
| Q47799371 | Cocaine Withdrawal Impairs mGluR5-Dependent Long-Term Depression in Nucleus Accumbens Shell Neurons of Both Direct and Indirect Pathways |
| Q42504124 | Combinatorial topography and cell-type specific regulation of the ERK pathway by dopaminergic agonists in the mouse striatum. |
| Q34269201 | Combined treatment with acupuncture reduces effective dose and alleviates adverse effect of L-dopa by normalizing Parkinson's disease-induced neurochemical imbalance |
| Q33575226 | Cyclic AMP and afferent activity govern bidirectional synaptic plasticity in striatopallidal neurons |
| Q38234309 | Direct and indirect pathways of basal ganglia: a critical reappraisal |
| Q42438586 | Dopaminergic control of motivation and reinforcement learning: a closed-circuit account for reward-oriented behavior. |
| Q38233462 | Dopaminergic modulation of striatal networks in health and Parkinson's disease |
| Q58749186 | Dual Dopaminergic Regulation of Corticostriatal Plasticity by Cholinergic Interneurons and Indirect Pathway Medium Spiny Neurons |
| Q90156490 | Dynamic postnatal development of the cellular and circuit properties of striatal D1 and D2 spiny projection neurons |
| Q38722989 | Dysregulation of striatal projection neurons in Parkinson's disease |
| Q35898412 | Endocannabinoid-dopamine interactions in striatal synaptic plasticity |
| Q36686382 | Endocannabinoids in striatal plasticity |
| Q57153012 | Endogenous repair mechanisms enhanced in Parkinson's disease following stem cell therapy |
| Q50200300 | Functional relevance of endocannabinoid-dependent synaptic plasticity in the CNS. |
| Q28264334 | GABA site agonist gaboxadol induces addiction-predicting persistent changes in ventral tegmental area dopamine neurons but is not rewarding in mice or baboons |
| Q49246060 | Glutamatergic Tuning of Hyperactive Striatal Projection Neurons Controls the Motor Response to Dopamine Replacement in Parkinsonian Primates |
| Q92425824 | Gutting the brain of inflammation: A key role of gut microbiome in human umbilical cord blood plasma therapy in Parkinson's disease model |
| Q41883668 | Heterogeneous properties of central lateral and parafascicular thalamic synapses in the striatum. |
| Q37213655 | Human striatal recordings reveal abnormal discharge of projection neurons in Parkinson's disease. |
| Q98286403 | Inhibition of striatonigral autophagy as a link between cannabinoid intoxication and impairment of motor coordination |
| Q42470816 | Input- and cell-type-specific endocannabinoid-dependent LTD in the striatum. |
| Q43163005 | Ischemic-LTP in striatal spiny neurons of both direct and indirect pathway requires the activation of D1-like receptors and NO/soluble guanylate cyclase/cGMP transmission. |
| Q48113066 | Levodopa treatment and dendritic spine pathology |
| Q27002626 | Levodopa-induced plasticity: a double-edged sword in Parkinson's disease? |
| Q96953382 | Long-Term Continuous Cervical Spinal Cord Stimulation Exerts Neuroprotective Effects in Experimental Parkinson's Disease |
| Q44345217 | Long-term plasticity of corticostriatal synapses is modulated by pathway-specific co-release of opioids through κ-opioid receptors |
| Q104509587 | Maternal stress programs accelerated aging of the basal ganglia motor system in offspring |
| Q40313187 | Metabolic, synaptic and behavioral impact of 5-week chronic deep brain stimulation in hemiparkinsonian rats. |
| Q47569238 | Motor learning and metaplasticity in striatal neurons: relevance for Parkinson's disease |
| Q38038559 | New synaptic and molecular targets for neuroprotection in Parkinson's disease |
| Q44342408 | Pathway- and Cell-Specific Kappa-Opioid Receptor Modulation of Excitation-Inhibition Balance Differentially Gates D1 and D2 Accumbens Neuron Activity |
| Q50092568 | Pathway-Specific Control of Striatal Neuron Vulnerability by Corticostriatal Cannabinoid CB1 Receptors. |
| Q34970674 | Phloroglucinol attenuates motor functional deficits in an animal model of Parkinson's disease by enhancing Nrf2 activity |
| Q41850307 | Preadolescent drd1-EGFP mice exhibit cocaine-induced behavioral sensitization |
| Q38520864 | Rational drug discovery design approaches for treating Parkinson's disease |
| Q48261352 | Rebalance of striatal NMDA/AMPA receptor ratio underlies the reduced emergence of dyskinesia during D2-like dopamine agonist treatment in experimental Parkinson's disease |
| Q37695363 | Recombineering strategies for developing next generation BAC transgenic tools for optogenetics and beyond. |
| Q30658223 | Rhes influences striatal cAMP/PKA-dependent signaling and synaptic plasticity in a gender-sensitive fashion. |
| Q64086843 | Spiny Projection Neuron Dynamics in Toxin and Transgenic Models of Parkinson's Disease |
| Q39381131 | Synaptic functions of endocannabinoid signaling in health and disease |
| Q42503102 | Temporal convergence of dynamic cell assemblies in the striato-pallidal network. |
| Q38099197 | The role of neuroplasticity in dopaminergic therapy for Parkinson disease. |
Search more.